View Cart (0 items)

Pharmaceutical

ARTICLES

Shire agrees to acquire NPS Pharma for $5.2 billion

British pharmaceutical company Shire plc has agreed to acquire U.S.-based NPS Pharma for $5.2 billion, strengthening its capabilities in treating rare diseases and gastrointestinal disorders.
Read More

Health Canada raises concerns over two Indian pharmaceutical facilities

Health Canada has asked Canadian importers to quarantine drug products manufactured at two facilities in India as a precautionary measure.
Read More

UK pharma industry welcomes government investment in science

The pharmaceutical industry in the United Kingdom has welcomed the government's Science and Innovation strategy, which was announced last week.
Read More

Japan's Otsuka to acquire Avanir Pharmaceuticals for $3.5 billion

The Japanese company said on Tuesday that this acquisition would strengthen its business in the area of neurological conditions.
Read More

New Eastman copolyester for medical products could allow faster processing

A styrene-free alternative to high-impact polystyrene (HIPS) for opaque medical packaging has been introduced by Eastman Chemical Company in the European market.
Read More

Roche to make diagnostic products in China

Roche is to establish a new diagnostic manufacturing facility in China, investing 450 million Swiss francs ($463 million) over the next three years.
Read More

Three Nigerian pharmaceutical firms get WHO certification

Three pharmaceutical manufacturers in Nigeria have been certified by the World Health Organization (WHO) to produce drugs in accordance with its Good Manufacturing Practice (GMP).
Read More

Consort agrees to $372 million acquisition of Aesica

U.K.-based healthcare company Consort Medical plc announced on Tuesday an agreement to acquire Aesica Pharmaceuticals.
Read More

PCI acquires clinical trail services company Biotec

Pharmaceutical packaging services provider PCI has expanded its presence in the European Union with the acquisition of Biotec Services International.
Read More

New heart failure drug could cut deaths by 20%

Swiss pharmaceuticals group Novartis is planning to launch a new drug that has the potential to cut cardiovascular death and admissions to hospital by 20%.
Read More